Date: 2024/12/06 - 00:00
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a clinical trial show 20% of participants who took Zepbound achieved significant weight loss compared to nearly 14% of participants who took Wegovy.
Date: 2024/11/27 - 02:32
A new study found an increased risk of cardiovascular events in people with irregular sleep patterns, even when they got the recommended amount of sleep. Conversely, more sleep regularity was protective against heart attack and stroke.